Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2020-2026

Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Infection Type
1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Infection Type: 2020 VS 2026
1.3.2 Urinary Tract Infections
1.3.3 Surgical Site Infections
1.3.4 Hospital-acquired Pneumonia
1.3.5 BloodStream Infections
1.3.6 Gastrointestinal Infections
1.4 Market by Application
1.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2020 VS 2026
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 ASCs
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2015-2026)
2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Regions
2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Healthcare-associated Infectious Disease Diagnostics Industry Dynamic
2.3.1 Healthcare-associated Infectious Disease Diagnostics Market Trends
2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Market Size
3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2019
3.5 Key Players Healthcare-associated Infectious Disease Diagnostics Area Served
3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Infection Type
4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Infection Type (2015-2020)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Infection Type (2021-2026)
5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2015-2020)
10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020))
11.1.5 Abbott Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
11.2.5 Accelerate Diagnostics Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
11.3.5 BD Recent Development
11.4 bioMrieux
11.4.1 bioMrieux Company Details
11.4.2 bioMrieux Business Overview
11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
11.4.5 bioMrieux Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
11.5.5 Bio-Rad Recent Development
11.6 DiaSorin Molecular
11.6.1 DiaSorin Molecular Company Details
11.6.2 DiaSorin Molecular Business Overview
11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
11.6.5 DiaSorin Molecular Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
11.8.5 Luminex Recent Development
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Details
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
11.9.5 Meridian Bioscience Recent Development
11.10 OpGen
11.10.1 OpGen Company Details
11.10.2 OpGen Business Overview
11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
11.10.5 OpGen Recent Development
11.11 QIAGEN
10.11.1 QIAGEN Company Details
10.11.2 QIAGEN Business Overview
10.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
10.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
10.11.5 QIAGEN Recent Development
11.12 Quidel
10.12.1 Quidel Company Details
10.12.2 Quidel Business Overview
10.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
10.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
10.12.5 Quidel Recent Development
11.13 Thermo Fisher Scientific
10.13.1 Thermo Fisher Scientific Company Details
10.13.2 Thermo Fisher Scientific Business Overview
10.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
10.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
10.13.5 Thermo Fisher Scientific Recent Development
11.14 Trinity Biotech
10.14.1 Trinity Biotech Company Details
10.14.2 Trinity Biotech Business Overview
10.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
10.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
10.14.5 Trinity Biotech Recent Development
11.15 Danaher
10.15.1 Danaher Company Details
10.15.2 Danaher Business Overview
10.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
10.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
10.15.5 Danaher Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Infection Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Urinary Tract Infections
Table 3. Key Players of Surgical Site Infections
Table 4. Key Players of Hospital-acquired Pneumonia
Table 5. Key Players of BloodStream Infections
Table 6. Key Players of Gastrointestinal Infections
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2021-2026)
Table 13. Healthcare-associated Infectious Disease Diagnostics Market Market Trends
Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers
Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges
Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints
Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players (2015-2020)
Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2019)
Table 20. Global Healthcare-associated Infectious Disease Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020) (US$ Million)
Table 25. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Infection Type (2015-2020)
Table 26. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Infection Type (2021-2026) (US$ Million)
Table 27. Global Healthcare-associated Infectious Disease Diagnostics Market Size Share by Application (2015-2020) (US$ Million)
Table 28. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2015-2020)
Table 29. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 30. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020) (US$ Million)
Table 31. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Infection Type (2015-2020)
Table 32. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2015-2020)
Table 36. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020) (US$ Million)
Table 37. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Infection Type (2015-2020)
Table 38. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 40. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2015-2020)
Table 42. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020) (US$ Million)
Table 43. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Infection Type (2015-2020)
Table 44. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 45. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 46. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 47. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2015-2020)
Table 48. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020) (US$ Million)
Table 49. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Infection Type (2015-2020)
Table 50. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 51. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 52. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 53. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2015-2020)
Table 54. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020) (US$ Million)
Table 55. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Infection Type (2015-2020)
Table 56. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 57. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 58. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 59. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2015-2020)
Table 60. Abbott Company Details
Table 61. Abbott Business Overview
Table 62. Abbott Healthcare-associated Infectious Disease Diagnostics Product
Table 63. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 64. Abbott Recent Development
Table 65. Accelerate Diagnostics Company Details
Table 66. Accelerate Diagnostics Business Overview
Table 67. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product
Table 68. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 69. Accelerate Diagnostics Recent Development
Table 70. BD Company Details
Table 71. BD Business Overview
Table 72. BD Healthcare-associated Infectious Disease Diagnostics Product
Table 73. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 74. BD Recent Development
Table 75. bioMrieux Company Details
Table 76. bioMrieux Business Overview
Table 77. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product
Table 78. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 79. bioMrieux Recent Development
Table 80. Bio-Rad Company Details
Table 81. Bio-Rad Business Overview
Table 82. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product
Table 83. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 84. Bio-Rad Recent Development
Table 85. DiaSorin Molecular Company Details
Table 86. DiaSorin Molecular Business Overview
Table 87. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product
Table 88. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 89. DiaSorin Molecular Recent Development
Table 90. F. Hoffmann-La Roche Company Details
Table 91. F. Hoffmann-La Roche Business Overview
Table 92. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product
Table 93. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 94. F. Hoffmann-La Roche Recent Development
Table 95. Luminex Business Overview
Table 96. Luminex Healthcare-associated Infectious Disease Diagnostics Product
Table 97. Luminex Company Details
Table 98. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 99. Luminex Recent Development
Table 100. Meridian Bioscience Company Details
Table 101. Meridian Bioscience Business Overview
Table 102. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product
Table 103. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 104. Meridian Bioscience Recent Development
Table 105. OpGen Company Details
Table 106. OpGen Business Overview
Table 107. OpGen Healthcare-associated Infectious Disease Diagnostics Product
Table 108. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 109. OpGen Recent Development
Table 110. QIAGEN Company Details
Table 111. QIAGEN Business Overview
Table 112. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product
Table 113. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 114. QIAGEN Recent Development
Table 115. Quidel Company Details
Table 116. Quidel Business Overview
Table 117. Quidel Healthcare-associated Infectious Disease Diagnostics Product
Table 118. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 119. Quidel Recent Development
Table 120. Thermo Fisher Scientific Company Details
Table 121. Thermo Fisher Scientific Business Overview
Table 122. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product
Table 123. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 124. Thermo Fisher Scientific Recent Development
Table 125. Trinity Biotech Company Details
Table 126. Trinity Biotech Business Overview
Table 127. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product
Table 128. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 129. Trinity Biotech Recent Development
Table 130. Danaher Company Details
Table 131. Danaher Business Overview
Table 132. Danaher Healthcare-associated Infectious Disease Diagnostics Product
Table 133. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020) (US$ Million)
Table 134. Danaher Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Infection Type: 2020 VS 2026
Figure 2. Urinary Tract Infections Features
Figure 3. Surgical Site Infections Features
Figure 4. Hospital-acquired Pneumonia Features
Figure 5. BloodStream Infections Features
Figure 6. Gastrointestinal Infections Features
Figure 7. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. ASCs Case Studies
Figure 11. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
Figure 12. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions: 2020 VS 2026
Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2021-2026)
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2019
Figure 16. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2019
Figure 18. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Abbott Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 44. Accelerate Diagnostics Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 45. BD Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 46. bioMrieux Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 47. Bio-Rad Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 48. DiaSorin Molecular Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 50. Luminex Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 51. Meridian Bioscience Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 52. OpGen Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 53. QIAGEN Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 54. Quidel Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 56. Trinity Biotech Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 57. Danaher Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs